who should not take glp-1 Are YOU a Slow/Non-Responder to GLP-1's? Why GLP-1 Medications Are Suddenly
Description
doi:10.3233/JPD-140364 226
Even in developed markets, affordability challenges can limit long-term adherence and patient uptake
Increased off-label use of these drugs is contributing to supply shortages for people who use these drugs for diabetes and employer health plans and insurers are scrutinizing the prescribing of the drugs
Am J Physiol Regul Integr Comp Physiol 307 , R465470, (2014)
Diabetic retinopathy complications have been observed with rapid glycemic improvement, particularly with semaglutide
